Ursula McCurry
Chief Tech/Sci/R&D Officer at IMUGENE LIMITED
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nick Ede | M | - | 11 years | |
| Paul Hopper | M | 68 | 12 years | |
| Leslie Chong | F | - | 9 years | |
| Michael Tonroe | M | 57 | 2 years | |
| Ursula Wiedermann | F | - | - | |
| Ciara Kennedy | M | 52 |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 years |
| Sharon Yavrom | M | - | 2 years | |
| Bradley Glover | M | 55 | 1 years | |
| Joseph Woodard | M | 58 | 1 years | |
| Anthony Good | M | - | - | |
| Lesley Russell | M | 63 | 5 years | |
| Todd Watanabe | M | 56 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 years |
| Jens Eckstein | M | 60 | 5 years | |
| Monil Shah | M | - | 3 years | |
| Jakob Dupont | M | 58 | 2 years | |
| Kimberlee Drapkin | F | 56 | 1 years | |
| John Byon | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Angie You | M | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 4 years |
| Patricia Millican | F | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 15 | 78.95% |
| United States | 4 | 21.05% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ursula McCurry
- Personal Network
